Host modulation: controlling the inflammation to control the infection

被引:138
作者
Bartold, P. Mark [1 ]
Van Dyke, Thomas E. [2 ,3 ]
机构
[1] Univ Adelaide, Dept Dent, Adelaide, SA, Australia
[2] Forsyth Inst, Ctr Periodontol, Dept Appl Oral Sci, Clin & Translat Res, Cambridge, MA USA
[3] Forsyth Inst, Ctr Periodontol, Dept Appl Oral Sci, Cambridge, MA USA
基金
澳大利亚国家健康与医学研究理事会;
关键词
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; GINGIVAL CREVICULAR FLUID; PERIODONTAL-DISEASE; POLYMICROBIAL SYNERGY; ADJUNCTIVE TREATMENT; DENTAL PLAQUE; PATHOGENESIS; RISK; AZITHROMYCIN; MANAGEMENT;
D O I
10.1111/prd.12169
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Historically, periodontal disease (gingivitis and periodontitis) has been recognized as being primarily of bacterial origin. However, recent evidence indicates that while bacteria are necessary for disease development they are not sufficient for the clinical manifestation of the many and varied forms of periodontal disease. It is becoming increasingly apparent that it is the host inflammatory response to the subgingival bacteria that is responsible for the tissue damage and, most likely, progression of the disease. We explore the concept that it is the subgingival microenvironment modified by the inflammatory response that leads to a change from a commensal to pathogenic microbiota. In this review, we examine the evidence for the emerging paradigm supporting the central role of inflammation rather than specific microbiota in the pathogenesis of periodontitis, and that by controlling the inflammation, it is possible to control the infection. As an extension of this, we propose a working model for the ongoing monitoring of periodontal patients using the medical model of treat to target'.
引用
收藏
页码:317 / 329
页数:13
相关论文
共 70 条
  • [1] Atzeni F, 2009, CURR OPIN INVEST DR, V10, P1204
  • [2] The Oral Microbiota: Living with a Permanent Guest
    Avila, Maria
    Ojcius, David M.
    Yilmaz, Oezlem
    [J]. DNA AND CELL BIOLOGY, 2009, 28 (08) : 405 - 411
  • [3] Gingival crevicular fluid as a source of biomarkers for periodontitis
    Barros, Silvana P.
    Williams, Ray
    Offenbacher, Steven
    Morelli, Thiago
    [J]. PERIODONTOLOGY 2000, 2016, 70 (01) : 53 - 64
  • [4] Antibacterial and immunomodulatory properties of azithromycin treatment implications for periodontitis
    Bartold, P. M.
    du Bois, A. H.
    Gannon, S.
    Haynes, D. R.
    Hirsch, R. S.
    [J]. INFLAMMOPHARMACOLOGY, 2013, 21 (04) : 321 - 338
  • [5] Periodontitis: a host-mediated disruption of microbial homeostasis. Unlearning learned concepts
    Bartold, P. Mark
    Van Dyke, Thomas E.
    [J]. PERIODONTOLOGY 2000, 2013, 62 : 203 - 217
  • [6] Effect of increased community and professional awareness of plaque control on the management of inflammatory periodontal diseases
    Bartold, PM
    Seymour, GJ
    Cullinan, MP
    Westerman, B
    [J]. INTERNATIONAL DENTAL JOURNAL, 1998, 48 (03) : 282 - 289
  • [7] Cardiovascular Risk with Non-steroidal Anti-inflammatory Drugs: Clinical Implications
    Bello, Alfonso E.
    Holt, Robert J.
    [J]. DRUG SAFETY, 2014, 37 (11) : 897 - 902
  • [8] Omega-3 fatty acids as an adjunct for periodontal therapy-a review
    Chee, B.
    Park, B.
    Fitzsimmons, T.
    Coates, A. M.
    Bartold, P. M.
    [J]. CLINICAL ORAL INVESTIGATIONS, 2016, 20 (05) : 879 - 894
  • [9] CLARKE NG, 1995, J CLIN PERIODONTOL, V22, P136
  • [10] Porphyromonas gingivalis as a Potential Community Activist for Disease
    Darveau, R. P.
    Hajishengallis, G.
    Curtis, M. A.
    [J]. JOURNAL OF DENTAL RESEARCH, 2012, 91 (09) : 816 - 820